Get started
Author

Anwar Goheer

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
2004 · Peter F. Bross, Robert Kane, et al. · Clinical Cancer Research · 343
PDF
FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
2020 · Sonia Singh, Adnan A. Jaigirdar, et al. · Clinical Cancer Research · 106
Regulatory science: a special update from the United States Food and Drug Administration
2000 · Kuei-Meng Wu, Joseph G. DeGeorge, et al. · Toxicology Letters · 29
Regulatory Toxicology Perspectives on the Development of Botanical Drug Products in the United States
2004 · Kuei-Meng Wu, James Farrelly, et al. · American Journal of Therapeutics · 25
Data from FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
2023 · Sonia Singh, Adnan A. Jaigirdar, et al.
Supplementary Tables S1 and S2 from FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
2023 · Sonia Singh, Adnan A. Jaigirdar, et al.
Data from FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
2023 · Sonia Singh, Adnan A. Jaigirdar, et al.
Supplementary Tables S1 and S2 from FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
2023 · Sonia Singh, Adnan A. Jaigirdar, et al.
Report from the FDA Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
2004 · Peter Bross, Robert C. Kane, et al.
Works count: 9
Citation count: 503
H-index: 4
I10-index: 4
Year
Topic
Type